
    
      To demonstrate equivalence within the 80% to 125% margin of the reference product for the
      baseline corrected area under the follicle-stimulating hormone (FSH) serum concentration-time
      curve from time zero to the last quantifiable concentration of AFOLIA compared to the
      reference product (United States [US] Gonal-fÂ® RFF)
    
  